Physician

Daniel V Alexander, D.O.

According to 2025 Medicare claims, Daniel Alexander, D.O. (NPI: 1184841470) practices cardiology in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Berkeley, WV. This provider's primary affiliated billing organization is VALLEY PHYSICIAN ENTERPRISE, INC. (NPI: 1366944670; TIN: 26-2767279) and primary practice location at 22601-2808. Alexander is affiliated with the ACO West Virginia (ACO ID: A3563) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Alexander's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,595 traditional Medicare patients, billed 3,564 HCPCS/CPT codes, and received $269,568 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,924 prescription claims across 615 beneficiaries totaling $917,001 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 43 claims. Open Payments data shows 95 records totaling $6,494. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $203,737 to $917,001. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,300 and ending at $3,614.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,027	5,068	$222,641
2016	1,337	2,949	$228,862
2017	1,419	4,760	$328,755
2018	1,448	4,903	$319,087
2019	1,718	4,485	$286,714
2020	1,866	4,060	$287,528
2021	1,900	4,369	$292,289
2022	1,925	4,611	$303,068
2023	1,772	4,090	$257,874
2024	1,595	3,564	$269,568

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	451	2,907	$203,737
2016	343	1,529	$158,629
2017	262	1,368	$225,040
2018	293	1,648	$352,114
2019	349	1,848	$418,885
2020	378	1,929	$493,914
2021	429	1,943	$540,428
2022	418	1,866	$576,867
2023	439	1,742	$569,680
2024	615	2,924	$917,001

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$1,823
2016	N/R	23	$1,253
2017	N/R	88	$28,214
2018	N/R	65	$4,905
2019	N/R	43	$1,985
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	356	390	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	226	235	$60
93280	Programming of dual lead pacemaker system	241	277	$57
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	446	559	$21
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	566	646	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	477	28,968	$549,969
Xarelto	Rivaroxaban	115	7,770	$140,218
Multaq	Dronedarone Hcl	30	1,860	$48,023
Dofetilide	Dofetilide	209	15,473	$46,186
Entresto	Sacubitril/Valsartan	39	2,324	$45,436

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$6,494	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel V. Alexander, D.O.?

Tedicare shows public-source Medicare data for Daniel V. Alexander, D.O. (NPI 1184841470), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel V. Alexander, D.O. have ACO affiliation data?

Daniel V. Alexander, D.O. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Daniel V. Alexander, D.O.?

Daniel V. Alexander, D.O. is linked to VALLEY PHYSICIAN ENTERPRISE, INC. (billing NPI 1366944670) in the available physician profile data.

Does Daniel V. Alexander, D.O. have Open Payments data?

Daniel V. Alexander, D.O. has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.